<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02001766</url>
  </required_header>
  <id_info>
    <org_study_id>H-2-2011-070</org_study_id>
    <nct_id>NCT02001766</nct_id>
  </id_info>
  <brief_title>ATP Release and Sympathetic Nerve Activity in Patients With Type II Diabetes</brief_title>
  <official_title>ATP Release and Sympathetic Nerve Activity in Patients With Type II Diabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Anders Rasmussen Rinnov</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rigshospitalet, Denmark</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Type II diabetes (T2D) is characterized by endothelial dysfunction, resulting in a poor&#xD;
      tissue perfusion and function as well as an increased risk of cardiovascular events. ATP,&#xD;
      which is released from the red blood cells, contributes to the regulation of the blood flow&#xD;
      and studies have shown that red blood cells taken from T2D patients have an impaired ability&#xD;
      to release ATP. However, it is not known whether the changes in the ATP system is an&#xD;
      underlying cause of the poor tissue perfusion observed in T2D. The purpose of project 1 is to&#xD;
      test the hypothesis that the deterioration in blood flow in T2D is caused by a reduced&#xD;
      release ATP from red blood cells, and to test if pharmacological manipulation of cAMP will&#xD;
      normalize ATP release, plasma ATP levels and thereby blood flow.&#xD;
&#xD;
      Furthermore, epidemiological studies show a clear link between regular exercise and a reduced&#xD;
      risk of serious cardiovascular disease. The extent to which a physically active lifestyle may&#xD;
      improve endothelial function in T2D is unknown. Regular physical activity improves&#xD;
      vascularization and induces an anti-inflammatory environment. Both the angiogenic and&#xD;
      anti-inflammatory effects of physical activity is in part mediated by substances released&#xD;
      from the active muscle. These muscle-derived substances are classified as myokines and have&#xD;
      paracrine, autocrine and endocrine effects and may thereby affect distant tissues. The&#xD;
      purpose of the project 2 is to investigate whether high intensity interval training may&#xD;
      reverse endothelial dysfunction in T2D through increased release of ATP and myokines. In&#xD;
      individuals with T2D we will determined blood flow in the muscle tissue using advanced&#xD;
      ultrasound. In addition, using intravascular and intramuscular microdialysis we will&#xD;
      determine ATP levels in blood and in the muscle interstitium.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>February 2013</start_date>
  <completion_date type="Anticipated">August 2016</completion_date>
  <primary_completion_date type="Anticipated">August 2016</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Glucose metabolism</measure>
    <time_frame>12 weeks</time_frame>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">45</enrollment>
  <condition>Type 2 Diabetes</condition>
  <arm_group>
    <arm_group_label>High intensity exercise</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>3 times per week in a total of 12 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low intensity exercise</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>3 times per week in a total of 12 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Normal lifestyle for 12 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Exercise training</intervention_name>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>High intensity exercise</arm_group_label>
    <arm_group_label>Low intensity exercise</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Type 2 diabetics&#xD;
&#xD;
          -  BMI &gt;30&#xD;
&#xD;
          -  Non smokers&#xD;
&#xD;
          -  Physical Inactive (less than 2 hours per week)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Thyroid disorder&#xD;
&#xD;
          -  Known ischemic heart disease (intermittent claudication, angina)&#xD;
&#xD;
          -  Diabetic eye disease&#xD;
&#xD;
          -  Diabetic kidney disease&#xD;
&#xD;
          -  Known heart disease&#xD;
&#xD;
          -  Intake of beta-blockers&#xD;
&#xD;
          -  Blood Pressure &gt; 140/90&#xD;
&#xD;
          -  Nephropathy and macroalbuminuria GFR measurement&#xD;
&#xD;
          -  Acute illness within the last three weeks&#xD;
&#xD;
          -  Chronic disease, including cancer, heart (ischemic and claudication), liver, kidney&#xD;
             and respiratory disorders (asthma)&#xD;
&#xD;
          -  Significant peripheral diabetic neuropathy (severe sensory disturbances)&#xD;
&#xD;
          -  Significant peripheral diabetic angiopathy (former or current foot ulcer)&#xD;
&#xD;
          -  Rheumatological disorders&#xD;
&#xD;
          -  Pregnancy or childbirth within the past three months&#xD;
&#xD;
          -  Alcohol abuse&#xD;
&#xD;
          -  smokers&#xD;
&#xD;
          -  Use of illegal performance-enhancing drugs (see IAAF list)&#xD;
&#xD;
          -  Injuries and / or surgery within the last 6 months&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stefan P. Mortensen, Dr. Med.</last_name>
    <role>Study Chair</role>
    <affiliation>Centre of Inflammation and Metabolism</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kamilla Winding, MSc PhD</last_name>
    <phone>+4535459574</phone>
    <email>kamilla.winding@regionh.dk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Centre of Inflammation and Metabolism (CIM), Rigshospitalet, Tagensvej 20, section M7641</name>
      <address>
        <city>Copenhagen</city>
        <zip>2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kamilla Winding, MSc PhD</last_name>
      <phone>+45 35459574</phone>
      <email>kamilla.winding@regionh.dk</email>
    </contact>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>June 2015</verification_date>
  <study_first_submitted>November 19, 2013</study_first_submitted>
  <study_first_submitted_qc>November 28, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 5, 2013</study_first_posted>
  <last_update_submitted>June 15, 2015</last_update_submitted>
  <last_update_submitted_qc>June 15, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 16, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Rigshospitalet, Denmark</investigator_affiliation>
    <investigator_full_name>Anders Rasmussen Rinnov</investigator_full_name>
    <investigator_title>CIM administrator</investigator_title>
  </responsible_party>
  <keyword>High intensity exercise</keyword>
  <keyword>Glycemic control</keyword>
  <keyword>Exercise</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

